EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study

Shobna Sawry iD, Kassahun Ayalew, Gloria Maimela, Melissa Briggs-Hagen, Marelize van Wyk-Heath, Simangele Mthethwa, Sannie Shai, Nkululeko N Mngomezulu, Lawrence Tlhowe, Josephine Achere-Darko, Jason Bedford, Catherine E Martin und 2 weitere

HIV Medicine · 2024

DOI: 10.1111/hiv.13638 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift HIV Medicine, 2024. Verfasst von Shobna Sawry und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wits RHI, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Weight Gain, HIV Infections, Pyridones, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although dolutegravir (DTG) is deemed stable, safe, cost‐effective, and clinically beneficial, it also carries the risk of side effects, including observed weight gain among patients on DTG ‐based antiretroviral therapy ( ART ) regimens. We compared weight changes among adults (≥18 years) initiating tenofovir disoproxil fumarate, lamivudine, and dolutegravir ( TLD ) or tenofovir disoproxil fumarate, emtricitabine, and efavirenz ( TEE) regimens and those switching from TEE to TLD ( TEE‐to‐TLD switchers) in three large primary care facilities in South Africa Methods We conducted a retrospective longitudinal record review using patient medical records, extracting relevant demographic and clinical data from October 2018 to June 2021 from randomly selected adults who initiated TLD or TEE (initiators) and adult TEE‐to‐TLD switchers. We assessed weight, body mass index ( BMI ), and percentage weight changes for both groups and fitted linear regression and generalized linear models to determine factors associated with weight and BMI change and percentage weight change ≥10%, respectively, among treatment initiators. We fitted linear mixed‐effect models among TEE‐to‐TLD switchers to consider repeated measures.

Results

Of 860 initiators, 450 (52.3%) initiated on TEE and 410 (47.7%) on TLD , with median follow‐up of 1.4 years and 1.0 year, respectively. At initiation, 43.3% on TEE and 40.8% on TLD were overweight or obese. TLD initiators had an adjusted higher mean weight gain of 1.6 kg ( p < 0.001) and mean BMI gain of 0.51 kg/m 2 ( p < 0.001) than TEE initiators. Independent risk factors for higher mean weight and BMI included age ≥50 years, male, on ART for >12 months, initial BMI of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight GainHIV InfectionsPyridonesHeterocyclic Compounds, 3-RingOxazinesBenzoxazinesAlkynesCyclopropanesHumansMaleFemaleAdultSouth AfricaRetrospective StudiesMiddle AgedPiperazinesAnti-HIV AgentsLongitudinal StudiesBody Mass IndexLamivudineTenofovirEmtricitabineDolutegravir

Stichwörter der Autor:innen

ARTHIVdolutegravirroutine careweight gain

Substanzen

PyridonesHeterocyclic Compounds, 3-RingOxazinesBenzoxazinesAlkynesCyclopropanesPiperazinesAnti-HIV AgentsLamivudineTenofovir

Autor:innen und Institutionen

  • Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
  • Division of Global HIV and TB, Centers for Disease Control and Prevention (CDC), Pretoria, South Africa.
  • Division of Global HIV and TB, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.

ORCID-Profile: Shobna Sawry

Förderung

  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Sawry, S., Ayalew, K., Maimela, G., Briggs-Hagen, M., van Wyk-Heath, M., Mthethwa, S., Shai, S., Mngomezulu, N. N., Tlhowe, L., Achere-Darko, J., Bedford, J., Martin, C. E., Fairlie, L., & Imrie, J. (2024). Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. HIV Medicine. https://doi.org/10.1111/hiv.13638

Vancouver

Sawry S, Ayalew K, Maimela G, Briggs-Hagen M, van Wyk-Heath M, Mthethwa S, et al. Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. HIV Medicine. 2024. doi:10.1111/hiv.13638

BibTeX
@article{Sawry2024,
  author = {Sawry, Shobna and Ayalew, Kassahun and Maimela, Gloria and Briggs-Hagen, Melissa and van Wyk-Heath, Marelize and Mthethwa, Simangele and Shai, Sannie and Mngomezulu, Nkululeko N and Tlhowe, Lawrence and Achere-Darko, Josephine and Bedford, Jason and Martin, Catherine E and Fairlie, Lee and Imrie, John},
  title = {Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study},
  journal = {HIV Medicine},
  year = {2024},
  doi = {10.1111/hiv.13638}
}
Kostenlos starten →